Is Amgen Inc. (NASDAQ:AMGN) A Safe Bet For Investors?


Amgen Inc. (NASDAQ:AMGN) closed its last session at $179.52. The stock traded within a range of $174.06 and $180.31. The company operates in the Healthcare sector with a market capitalization of 130.69 Million. Trading volume for Amgen Inc. was 5.92 Million in its previous trading session. Currently, Amgen Inc. (NASDAQ:AMGN) has an average volume of 3.27 Million.

Company Profile

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives.

Analyst Views

Amgen Inc. (NASDAQ:AMGN) received a Buy rating from 2 analysts. 0 analysts gave its stock an Outperform rating. 6 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

Amgen Inc. (NASDAQ:AMGN) touched its 1-Year High price of $201.23 on 01/29/18 and its 1-Year Low price of $152.16 on 05/23/17.

EPS & Financials

Amgen Inc. (NASDAQ:AMGN) reported its EPS in the last quarter as $2.69/Share lagging the analyst estimate of $3.03/Share by a difference of $-0.34. This showed a surprise of -11.2% in the last quarter earnings.

For the current quarter, 18 analysts are projecting a mean EPS of $3.21/share. According to their observations and findings, the stock could provide a high EPS of $3.42/share and a low EPS of $2.97/share.

Analysts believe that the company has the potential to earn average revenue of $5.41 Billion for the current quarter. According to their predictions high & low revenue estimates are 5.68 Billion and 5.23 Billion respectively.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. Amgen Inc. (NASDAQ:AMGN) has a 20-Day average volume of 4.68 Million. According to today’s trading volume Amgen Inc. is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BEARISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BULLISH trend as well.

The company currently has an insider ownership of 0.1 Percent and Institutional ownership of 81.9 Percent. The return on assets stands at 10.4%, Return on Equity currently is 26.3% and the Return on Investment value is 13%.

Amgen Inc. (NASDAQ:AMGN) gross margin percentage stands at 83.3% while its operating margin for the past trailing twelve month is 45.1 percent and its overall profit margin (ttm) is 35.8 Percent. The stock is currently moving below its 20-Day Simple Moving Average of -2.96% with a 50-Day Simple Moving Average of -0.75 percent. As of today, the company has a SMA200 (200-day simple moving average) of 2.63 Percent. The Stock has YTD (year to date) performance of 3.23 percent.

The TTM operating margin for the company stands at 45.1%. The return on invested capital is at 13%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 16.57.

The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 2.63%, and has a solid year to date (YTD) performance of 3.23% which means that the stock is constantly adding to its value from the previous fiscal year end price.